dc.contributor.author | del Fresno, Carlos | |
dc.contributor.author | Sancho, David | |
dc.date.accessioned | 2019-07-03T13:36:22Z | |
dc.date.available | 2019-07-03T13:36:22Z | |
dc.date.issued | 2019-07 | |
dc.identifier.citation | Trends Immunol. 2019; 40(7):559-561 | es_ES |
dc.identifier.issn | 1471-4906 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/7846 | |
dc.description.abstract | Type-I conventional dendritic cells (cDC1s) are key in inducing adaptive immunity. Using single-cell sequencing, Ginhoux and colleagues (Immunity 2019;50:1069-1083.e8) find that a subset of activated cDC1s in bacteria-infected skin is critical for neutrophil recruitment via the production of VEGF-α. These results reveal a crucial function for cDC1s beyond antigen presentation. | es_ES |
dc.description.sponsorship | C.d.F. is supported by AECC Foundation as recipient of an ‘Ayuda Fundación Científica AECC a personal investigador en cancer’. Work in the D.S. laboratory is funded by the CNIC and grant SAF2016-79040-R
from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), Agencia Estatal de Investigación and FEDER (European Fund for Regional Development); B2017/BMD-3733 Immunothercan-CM
from Comunidad de Madrid; RD16/0015/0018-REEM from FIS-Instituto de Salud Carlos III, MINECO and FEDER; Foundation Acteria; Constantes y Vitales prize (Atresmedia); Foundation La Marató de TV3 (201723); the European Commission (635122-PROCROP H2020) and the European Research Council (ERCConsolidator Grant 725091). The CNIC is supported by the MINECO and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Cell Press | es_ES |
dc.type.hasVersion | AM | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | cDC1s: New Orchestrators of Tissue Innate Immunity | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.identifier.pubmedID | 31133464 | es_ES |
dc.format.volume | 40 | es_ES |
dc.format.number | 7 | es_ES |
dc.format.page | 559-561 | es_ES |
dc.identifier.doi | 10.1016/j.it.2019.05.002 | es_ES |
dc.contributor.funder | Asociación Española Contra el Cáncer | |
dc.contributor.funder | Ministerio de Economía, Industria y Competitividad (España) | |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
dc.contributor.funder | Comunidad de Madrid (España) | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Fondation ACTERIA (Acting on European Research in Immunology and Allergology) | |
dc.contributor.funder | Fundación La Marató TV3 | |
dc.contributor.funder | Unión Europea. Comisión Europea | |
dc.contributor.funder | European Research Council | |
dc.contributor.funder | Fundación ProCNIC | |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1471-4981 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/j.it.2019.05.002 | es_ES |
dc.identifier.journal | Trends in immunology | es_ES |
dc.repisalud.orgCNIC | CNIC::Grupos de investigación::Inmunobiología | es_ES |
dc.repisalud.institucion | CNIC | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SAF2016-79490-R | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/RD16/0015/0018-REEM | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/635122 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/725091 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/ES/SEV-2015-0505 | es_ES |
dc.rights.accessRights | embargoed access | es_ES |